Sharekhan Assigns Buy To Mid Cap Stock, Downgrades Small Cap Stock To Hold
Sharekhan has assigned buy call to mid- cap stock, Can Fin Homes and hold call to small cap stock, Gland Pharma.
The brokerage firm has downgraded Gland Pharma to hold with a target price of Rs The broker 1689 a apiece and apiece and a potential return of apiecepiece .age Rs 670.
The last trading price of the mid cap stock is Rs 535 apiece with intraday gain of 0 .92%.
Sharekhan has recommended investors to buy Can Fin Homes with a target price of Rs 670 apiece and a potential return of 26%.
The company has a market capitalisation of Rs 7125 crore. The stock has given maximum 35% return in last 3- years.
The shares have rallied 12% in last 3- months. The mid cap stock operates in NBFC sector.
2. Hold Gland Pharma With Price Target Of Rs 1689
The last trading price of the small cap Pharmaceuticals stock is Rs 1576 apiece. The company has a market capitalisation of Rs 25,958 crore.
The stock has fallen 59% in last 1- year.
Sharekhan has suggested investors to hold the stock of Gland Pharma with a target price of Rs 1689 apiece.
According to Sharekhan, " We value the company's shares at 17 .6 x ( 27 % discount to its two- years' historical PE), while applying it on FY2025E EPS."
Disclaimer
The stocks have been picked from the brokerage report of Sharekhan.
Greynium Information Technologies, the Author, and the respective Brokerage House are not liable for any losses caused as a result of decisions based on the article.
Goodreturns.in advises users to check with certified experts before taking any investment decision.
By Renu Baliyan Goodreturns source: goodreturns.in Dailyhunt